Entecavir shows promise as an alternative treatment for hepatitis B

被引:0
作者
不详
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:401 / 401
页数:1
相关论文
共 50 条
[41]   Successful treatment of an entecavir-resistant hepatitis B virus variant [J].
Yatsuji, Hiromi ;
Hiraga, Nobuhiko ;
Mori, Nami ;
Hatakeyama, Tsuyoshi ;
Tsuge, Masataka ;
Imamura, Michio ;
Takahashi, Shoichi ;
Fujimoto, Yoshifumi ;
Ochi, Hidenori ;
Abe, Hiromi ;
Maekawa, Toshiro ;
Suzuki, Fumitaka ;
Kumada, Hiromitsu ;
Chayama, Kazuaki .
JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (12) :1811-1817
[42]   "Real Life" outcomes for Tenofovir and Entecavir in the treatment of hepatitis B virus [J].
Khan, Bilal ;
Selvapatt, Nowlan ;
Ananthavarathan, Abbesega ;
Brown, Ashley S. .
HEPATOLOGY, 2015, 62 :1206A-1207A
[43]   Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection [J].
Chang, Kai-Chi ;
Wu, Jia-Feng ;
Hsu, Hong-Yuan ;
Chen, Huey-Ling ;
Ni, Yen-Hsuan ;
Chang, Mei-Hwei .
PEDIATRICS AND NEONATOLOGY, 2016, 57 (05) :390-395
[44]   Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B [J].
Wong, Vincent Wai-Sun ;
Wong, Grace Lai-Hung ;
Yiu, Karen Kar-Lum ;
Chim, Angel Mei-Ling ;
Chu, Shirley Ho-Ting ;
Chan, Hoi-Yun ;
Sung, Joseph Jao-Yiu ;
Chan, Henry Lik-Yuen .
JOURNAL OF HEPATOLOGY, 2011, 54 (02) :236-242
[46]   Pharmacotherapy of Chronic Hepatitis B with Entecavir [J].
Palumbo, Emilio .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 :11-15
[47]   Hepatitis B virus resistance to entecavir [J].
Hidalgo-Tenorio, Carmen ;
Rivero, Mar ;
Alvarez, Marta ;
Garcia, Federico .
MEDICINA CLINICA, 2012, 139 (05) :228-229
[48]   Entecavir for chronic hepatitis B: A review [J].
Palumbo, Emilio .
THERAPEUTIC DRUG MONITORING, 2008, 30 (01) :1-4
[49]   Entecavir Efficiency in Chronic Hepatitis B [J].
Grecu, Nicolae ;
Preda, Carmen ;
Soare, Alina ;
Stefan, Gabriel ;
Andrei, Stefan .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 :31-32
[50]   Entecavir (Baraclude) for chronic hepatitis B [J].
不详 .
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1210) :47-48